Company intelligence / Profile preview

Sichuan Qingmu Pharmaceutical

Meishan, Sichuan Province, Chinaqingmupharm.com ↗

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Sichuan Qingmu Pharmaceutical specializes in R&D and manufacturing of generic small molecule APIs and advanced intermediates. The company provides CDMO/CMO services for small molecule drugs. It has commercialized several key API products such as bisoprolol and dabigatran in China and regulated international markets. The company holds GMP certifications for multiple APIs with regulatory approvals including USDMF, J-MF, CEP/COS; it has passed inspections by the US FDA, Korea MFDS, China NMPA among others. Products are exported to over 40 countries worldwide.

Therapeutic areas: Men's HealthOncologyOtherRheumatologyCardiovascularNeurology
Modalities: Small moleculeGeneric APIs (Active Pharmaceutical Ingredients)Advanced intermediates
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Sichuan Qingmu Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichuan Qingmu Pharmaceutical.